In my experience, orthopedic surgeons are the most fanatical of all surgeons regarding infection prevention. It makes sense since much of their work involves implanting hardware into bones – and an infection in a bone, let alone in the presence of hardware, is very tough to eradicate. So, when a new study looks at orthopedic thought on infection prevention, it is worth considering.
Pull incentives to fix the broken antibiotic marketplace – like a subscription payment of several billion dollars per needed antibiotic – are finally going to be implemented in 2032. What happens then? But before we get there … a brief word about blogging on Google’s Blogger.
The U.S. dithers, Europe ponders and the extinction of life-saving antibiotics continues apace.
Will there be pull incentives to support the broken antibiotics market? Where is Biden?
We learn more and more every day about the bacteria, viruses, and fungi that live within us and support us. It's our own personal world: the microbiome. And researchers have identified ecologic niches with varying microbial occupants. And it seems that cities have unique microbiomes, too.
Are there methods that can be employed to ensure the commercial success of antibiotic biotech? ACSH advisor Dr. David Shlaes has his doubts.
Fish + bacteria = 25% mortality. Fish + bacteria + rocks = 5% mortality. What magic lies within the rocks? What can farm-raised fish teach us?
What would happen if we approached antibiotic resistance with the same fervor that we have for covid? Is there a reason why we should not?
Even in the time of COVID-19, antibiotic resistance remains a problem. Is it a particle or a wave? - turns out it may be neither. Zombies get all the press, but are vampires the real problem? Theory or practice? Finally, more on the science of gift-giving.
A European study found that 44% of "antibiotic-free" animal feed samples tested contained antibiotics.
The US Centers for Disease Control recently released its new report, Antibiotic Resistant Threats in the United States, 2019. ACSH Advisor Dr. David Shlaes discusses its pros and cons.
When there is little if any money to be made curing a disease, non-profits could come to the rescue.